DeNovix CellDrop becomes first ACT® label certified automated cell counter
The DeNovix CellDrop™ Automated Cell Counter has achieved ACT® Label certification from My Green Lab®, making it the first automated cell counter accredited by the program.
Lactobacillus iners in tumors: Driving chemoradiation resistance via lactate-induced metabolic rewiring
Investigating tumor and gut microbiome traits that impact chemoradiation therapy in patients with cervical cancer.
CDC signs decision memo allowing Novavax monovalent COVID-19 boosters for adults
Today, CDC's Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo allowing Novavax monovalent COVID-19 boosters for adults.
Abnormal electrical activity in the brain of people with Alzheimer’s leads to epileptic seizures
Alzheimer's disease causes death of neurons, and researchers hypothesize this may contribute to abnormal electrical activity in the brain that leads to epileptic seizures.
Using opioid settlement cash for police gear like squad cars and scanners sparks debate
Policing expenses mount quickly: $25,000 for a law enforcement conference about fentanyl in Colorado; $18,000 for technology to unlock cellphones in Southington, Connecticut; $2,900 for surveillance cameras and to train…
Quick genetic test offers hope for sick, undiagnosed kids. but few insurers offer to pay.
Just 48 hours after her birth in a Seattle-area hospital in 2021, Layla Babayev was undergoing surgery for a bowel obstruction.
AI-based MRI tools show promise in multiple sclerosis diagnosis
A groundbreaking study in NPJ Digital Medicine demonstrates the superior accuracy of AI-based imaging in diagnosing and monitoring multiple sclerosis.
Empowerment boosts resilience: Stigma’s role in diabetes patients’ quality of life
A Chinese study reveals how empowerment influences the quality of life of diabetic patients by moderating the impact of stigma.
Million Hearts model cuts heart attack and stroke risk without hiking Medicare costs
The Million Hearts payment model, which incentivizes healthcare organizations to reduce cardiovascular risk among Medicare beneficiaries, led to a modest but significant reduction in new-onset myocardial infarctions and strokes over…
COVID-19 increases Alzheimer’s risk
The study explores the interconnected risks between COVID-19 and Alzheimer's Disease (AD), highlighting how SARS-CoV-2 can aggravate AD pathology through neuroinflammation and neurodegeneration. It raises significant concerns about the long-term…